VanEck Biotech ETF (BBH) est une société cotée en bourse dans le Services Financiers secteur, opérant dans le Asset Management secteur d'activité.
BBH a date d'introduction en bourse 1999-11-23, cotée sur le NASDAQ Global Market, une capitalisation boursière de $380.55M.
VanEck Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.
